Sciclone Pharmaceuticals Inc
SCLN
SCLN was delisted on the 13th of October, 2017.
104 hedge funds and large institutions have $147M invested in Sciclone Pharmaceuticals Inc in 2013 Q2 according to their latest regulatory filings, with 104 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
12% less call options, than puts
Call options by funds: $707K | Put options by funds: $806K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
Group One Trading
Chicago,
Illinois
| $4K | +$4.29K | +901 | New |
|
|
TRCT
102
Tower Research Capital (TRC)
New York
| $1K | +$952 | +200 | New |
|
|
LTFS
103
Ladenburg Thalmann Financial Services
Miami,
Florida
| – | +$124 | +26 | New |
|
|
SMA
104
Simply Money Advisors
Cincinnati,
Ohio
| – | +$428 | +90 | New |
|
SCLN Hedge Fund Activity: Q2 2013 in Review
104 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q2 2013, worth a combined $147M.
Buyers outnumbered sellers: 104 funds opened new SCLN positions and 0 closed out — a net gain of 104 holders — while 0 added to existing stakes and 0 trimmed.
- 104 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $147M of Sciclone Pharmaceuticals Inc stock for Q2 2013.
- 104 funds opened new Sciclone Pharmaceuticals Inc positions in Q2 2013 and 0 closed out, a net change of +104 holders.
Based on aggregated 13F filings for Q2 2013.